P2RY12 and ovarian cancer: Moreover, in a model of orthotopic ovarian cancer, induced by the injection of the A2780 human ovarian cancer cells into nude mice, the reversible P2Y12-R inhibitor ticagrelor diminished the growth of primary tumors when administered by daily gavage [89].